Registration Now Open for BOS Events 2024!

Bio2Business Ltd is delighted to open registration for BOS Events 2024 which includes: BOS Basel 2024, which will take place on the 19th and 20th of June at Congress Centre Basel; and BOS Manchester 2024, which will take place on the 26th and 27th of November at Manchester Central.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for virtual events during 2024. We look forward to welcoming you and your colleagues to BOS Events 2024! Please contact the Bio2Business team for further details.

Follow us on LinkedIn to see our latest announcements


Featured Company (BOS Manchester 2024)

Logo for M3 Pharma Consultancy
M3 Pharma Consultancy
M3 Pharma Consultancy is a Dutch consultancy company dedicated to support the development of new medicinal products. Support can be provided at any stage, e.g. from defining phase-appropriate CMC strategies for pharma/biotech clients to coordinating their outsourced activities at CDMO/CRO’s. With a...
View profile

Featured Speaker (BOS Basel 2024)

photo of Dr Dr Ulrich Rümenapp

In-house Manufacture or External Sourcing of Gene Editing Reagents to Support the Growing Cell and Gene Therapy Business

Dr Ulrich Rümenapp, Senior Program Lead, Bayer AG

ABSTRACT: Beyond small molecule drugs and classical biopharmaceuticals like antibodies, cell and gene therapies are becoming more and more important to treat patients with severe diseases. Genome editing holds a great promise for cell-based therapies. Reliable manufacture and supply of the reagents used for gene editing - in the necessary quality - is essential. Depending on the application, gene editing reagents (GERs) may be starting materials or drug substances to be made following GMP principles or under full GMP. For development, clinical and commercial manufacture, companies need to decide between... Click here to Read More